Compound Detail
CHEMBL346178
OSANETANT 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
CC(=O)N(C)C1(c2ccccc2)CCN(CCC[C@]2(c3ccc(Cl)c(Cl)c3)CCCN(C(=O)c3ccccc3)C2)CC1
Basic Information
| ChEMBL ID | CHEMBL346178 |
| Name | OSANETANT |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | DZOJBGLFWINFBF-UMSFTDKQSA-N |
12
Targets
49
Activities
3
Assay Types
19
PK Parameters
20
Publications
5
Known Names
1
Indications
Molecular Properties
606.6
MW (Da)
7.42
ALogP
3
HBA
0
HBD
43.9
PSA (Ų)
0.27
QED
2
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Prostatic Neoplasms
Activity Summary
Ki 29 meas. best 9.7
Kd 12 meas. best 10.1
IC50 8 meas. best 9.68
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | Kd | 10.1 | 10.01 | 0.1 | 2 |
| Neuromedin-K receptor CHEMBL3799 | Kd | 10.1 | 9.4733 | 0.1 | 3 |
| Neuromedin-K receptor CHEMBL4429 | Ki | 9.7 | 8.9375 | 0.2 | 12 |
| Neuromedin-K receptor CHEMBL4429 | Kd | 9.7 | 8.3357 | 0.2 | 7 |
| Neuromedin-K receptor CHEMBL4429 | IC50 | 9.68 | 9.39 | 0.2 | 2 |
| Substance-K receptor CHEMBL4554 | Ki | 9.29 | 9.29 | 0.5 | 1 |
| Neuromedin-K receptor CHEMBL3799 | Ki | 9.22 | 9.16 | 0.6 | 2 |
| Gerbillinae CHEMBL612671 | Ki | 8.7 | 8.7 | 2.0 | 1 |
| Substance-K receptor CHEMBL2327 | Ki | 7.45 | 7.2525 | 35.5 | 4 |
| Neuromedin-K receptor CHEMBL3154 | Ki | 7.3 | 7.2633 | 50.1 | 3 |
| Substance-P receptor CHEMBL249 | Ki | 6.68 | 6.3367 | 209.6 | 6 |
| Neuromedin-K receptor CHEMBL3799 | IC50 | 6.5 | 6.5 | 320.0 | 1 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 6.0 | 6.0 | 1000.0 | 1 |
| Cytochrome P450 2C19 CHEMBL3622 | IC50 | 5.16 | 5.16 | 7000.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.01 | 5.01 | 9650.0 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 4.96 | 4.96 | 11000.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 4.26 | 4.26 | 55000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 114.27 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 57.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 57.0 | mL.min-1.kg-1 | Rattus norvegicus |
| F | 17.0 | % | Rattus norvegicus |
| F | 17.0 | % | Rattus norvegicus |
| Fu | 0.006 | - | Rattus norvegicus |
| Fu | 0.001 | - | Rattus norvegicus |
| Fu | 0.15 | nM | Rattus norvegicus |
| Fu | 0.09 | nM | Rattus norvegicus |
| T1/2 | 0.06683 | hr | Homo sapiens |
| T1/2 | 0.1705 | hr | Cavia porcellus |
| T1/2 | 0.165 | hr | Homo sapiens |
| T1/2 | 0.1683 | hr | Homo sapiens |
| T1/2 | 0.525 | hr | Cavia porcellus |
| T1/2 | 0.2905 | hr | Homo sapiens |
| T1/2 | 0.3833 | hr | Rattus norvegicus |
| T1/2 | 1.833 | hr | Rattus norvegicus |
| T1/2 | 2.017 | hr | Rattus norvegicus |
| Tmax | 0.75 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine